MGRM:NSD-Monogram Orthopaedics Inc. Common Stock (USD)

COMMON STOCK | Medical Devices |

Last Closing

USD 1.94

Change

+0.07 (+3.74)%

Market Cap

USD 0.07B

Volume

0.06M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-03 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

-0.55 (-0.42%)

USD 50.10B
ALGN Align Technology Inc

-2.06 (-0.75%)

USD 20.59B
PODD Insulet Corporation

+1.89 (+1.02%)

USD 12.65B
SWAV Shockwave Medical Inc

-0.75 (-0.23%)

USD 12.41B
BRKR Bruker Corporation

-0.75 (-0.99%)

USD 11.00B
MASI Masimo Corporation

+3.49 (+2.89%)

USD 6.17B
TMDX TransMedics Group Inc

+3.05 (+2.26%)

USD 4.36B
AXNX Axonics Modulation Technologie..

-0.12 (-0.18%)

USD 3.45B
LIVN LivaNova PLC

-0.92 (-1.46%)

USD 3.36B
PRCT Procept Biorobotics Corp

-0.04 (-0.06%)

USD 3.22B

ETFs Containing MGRM

SHLD Global X Funds 4.14 % 0.00 %

+0.01 (+0.04%)

USD 0.04B
CIBR First Trust NASDAQ Cybers.. 3.85 % 0.00 %

-0.08 (0.04%)

USD 6.24B
EEA:PA BNP Paribas Easy FTSE EPR.. 0.00 % 0.00 %

-0.05 (0.04%)

USD 0.07B
EEE:PA BNP Paribas Easy FTSE EPR.. 0.00 % 0.00 %

-0.05 (0.04%)

USD 0.20B
EEAA:F BNP Paribas Easy - FTSE E.. 0.00 % 0.00 %

N/A

USD 0.20B
IM2A:F BNP Paribas Easy - FTSE E.. 0.00 % 0.00 %

N/A

USD 0.20B
EEAA:XETRA BNP Paribas Easy FTSE EPR.. 0.00 % 0.00 %

-0.06 (0.04%)

USD 0.20B
IM2A:XETRA BNP Paribas Easy - FTSE E.. 0.00 % 0.00 %

-0.04 (0.04%)

USD 0.20B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -43.60% 20% F 11% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -43.60% 20% F 11% F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.07B 50% F 32% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector